LatinaBA (Blanchard y Asociados) vs a First-in-Human Device CRO (bioaccess®)

LatinaBA (Blanchard y Asociados) vs bioaccess®: what LatinaBA publishes, where it fits in Argentina, and when a medical-device first-in-human specialist in Latin America since 2010 is the better tool.

If you typed LatinaBA (Blanchard y Asociados) into a search box, you are probably building a CRO or site shortlist for Argentina. This article uses only what is public about LatinaBA (latinaba.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What LatinaBA publishes

LatinaBA, formerly Blanchard & Asociados, describes itself as a CRO with more than 16 years in Latin America, headquartered in Argentina with offices in Brazil and Chile and a US contracting office. Its site lists clinical operations, regulatory services, monitoring, medical and protocol writing, observational and RWE studies, clinical trial oversight and medical device research.

LatinaBA vs bioaccess®

Dimension LatinaBA bioaccess®
Core focus Full-service CRO and oversight, Latin America First-in-human and early feasibility studies for medical devices
Geography See provider site Latin America, since 2010
Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
After the trial See provider site Live multi-country sanitary registration and in-country holder service

Where each one fits

If you need a regional full-service CRO or sponsor oversight for drug trials in Latin America, LatinaBA’s published services match.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including LatinaBA, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Argentina. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the LatinaBA public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

← Back to Blog · Contact bioaccess®